Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062751
Status:
COMPLETED
Last Update Posted:
2011-04-15
First Post:
2003-06-12
Brief Title:
Study Evaluating Temsirolimus CCI-779 In Breast Neoplasms
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization Data
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Class:
INDUSTRY
Study ID:
3066A1-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Director Clinical Trial Disclosure Group
Old Organization:
Pfizer Inc
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |